340B Penny Pricing, Civil Monetary Penalty Revisions On Deck In Proposed Rule
Proposed rule will revisit controversial provisions in the January 340B final rule to address manufacturer concerns about the US discount program.
You may also be interested in...
Leaders of key health care committees urge HRSA to move ahead quickly with regulations, which might mean implementing a 2017 final rule or issuing a new proposed rule.
Azar didn’t bring much comforting news to attendees at the annual 340B Coalition conference, with a strong defense of cuts in reimbursement for providers who use the drug discount program. But he did suggest that the 'penny pricing' policy will be finalized soon.
House Energy & Commerce Committee recommends more oversight of hospital participation in the 340B drug discount program.